The Centers for Medicare & Medicaid Services (CMS) has revised its guidance on the add-on payment for COVID-19 patients. The guidance states that effective with admissions occurring on or after Sept. 1, claims eligible for the 20% increase in the Medicare Severity-Diagnosis Related Group weighting factor for cases with a COVID-19 diagnosis will also be required to have a positive COVID-19 laboratory test documented in the patient’s medical record.
This content is restricted to members.
